The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Clinical Relevance of Pretransplant Donor-Specific HLA Antibodies Detected by Single-Antigen Flow-Beads
Abstract
BACKGROUND: Defining the clinical relevance of donor-specific HLA-antibodies detected by single-antigen flow-beads (SAFB) is important because these assays are increasingly used for pretransplant risk assessment and organ allocation. The aims of this study were to investigate to which extent HLA-DSA detected by SAFB represent a risk for antibody-mediated rejection (AMR) and diminished allograft survival, and to define HLA-DSA characteristics predictive for AMR. METHODS: In this retrospective study of 334 patients with negative complement-dependent cytotoxicity crossmatches, day-of-transplant sera were analyzed by SAFB, HLA-DSA determined by virtual crossmatching, and the results correlated with the occurrence of AMR and allograft survival. RESULTS: Sixty-seven of 334 patients (20%) had HLA-DSA. The incidence of clinical/subclinical AMR at day 200 posttransplant was significantly higher in patients with HLA-DSA than in patients without HLA-DSA (55% vs. 6%; P<0.0001). Notably, 30/67 patients with HLA-DSA (45%) did not experience clinical/subclinical AMR. Death-censored 5-year allograft survival was equal in patient without HLA-DSA and patients with HLA-DSA but no AMR (89% vs. 87%; P=0.95), whereas it was 20% lower in patients with HLA-DSA and AMR (68%; P=0.002). The number, class, and cumulative strength of HLA-DSA determined by SAFB, and prior sensitizing events were not predictive for the occurrence of AMR. CONCLUSIONS: These results support the utility of SAFB for pretransplant risk assessment and organ allocation, and suggest that improvement of the positive predictive value of HLA-DSA defined by SAFB will require an enhanced definition of pathogenic factors of HLA-DSA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
Solez, K., Colvin, R. B., Racusen, L. C., Haas, M., Sis, B., Mengel, M., Halloran, P. F., Baldwin, W., Banfi, G., Collins, A. B., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02159.x · Cited by 1,857
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
Ekberg, H., Tedesco-Silva, H., Demirbas, A., Vítko, Š., Nashan, B., Gürkan, A., Margreiter, R., Hugo, C., Grinyó, J. M., Frei, U., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067411 · Cited by 1,810
Antibody-Mediated Renal Allograft Rejection: Diagnosis and Pathogenesis
Colvin, R. B. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010073 · Cited by 517
Stegall, M. D., Gloor, J., Winters, J. L., Moore, S. B., & DeGoey, S. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01178.x · Cited by 428
Nickeleit, V., Zeiler, M., Gudat, F., Thiel, G., & Mihatsch, M. J. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131242 · Cited by 311
A Structurally Based Approach to Determine HLA Compatibility at the Humoral Immune Level
Duquesnoy, R. J. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.08.001 · Cited by 285
Clinical Relevance of Preformed HLA Donor-Specific Antibodies in Kidney Transplantation
Lefaucheur, C., Suberbielle-Boissel, C., Hill, G. S., Nochy, D., Andrade, J., Antoine, C., Gautreau, C., Charron, D., & Glotz, D. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02072.x · Cited by 244
Transplanting the Highly Sensitized Patient: The Emory Algorithm
Bray, R. A., Nolen, J. D. L., Larsen, C., Pearson, T., Newell, K. A., Kokko, K., Guasch, A., Tso, P., Mendel, J. B., & Gebel, H. M. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01521.x · Cited by 216
Klitz, W., Maiers, M., Spellman, S., Baxter‐Lowe, L. A., Schmeckpeper, B., Williams, T. M., & Fernandez‐Viña, M. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00103.x · Cited by 179 · cited 1×
“HLA-DQ antigens were primarily inferred from the HLA-DR antigens, which are in strong linkage disequilibrium (12).”
BackgroundTransplant Accommodation in Highly Sensitized Patients: A Potential Role for Bcl-xL and Alloantibody
Salama, A. D., Delikouras, A., Pusey, C. D., Cook, H. T., Bhangal, G., Lechler, R. I., & Dorling, A. (2001) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2001.001003260.x · Cited by 176
Cited by
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
Lefaucheur, C., Loupy, A., Hill, G. S., Andrade, J., Nochy, D., Antoine, C., Gautreau, C., Charron, D., Glotz, D., & Suberbielle-Boissel, C. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009101065 · Cited by 789
Tait, B. D., Süsal, C., Gebel, H. M., Nickerson, P. W., Zachary, A. A., Claas, F. H. J., Reed, E. F., Bray, R. A., Campbell, P., Chapman, J. R., et al. (2013) · Transplantation · doi:10.1097/tp.0b013e31827a19cc · Cited by 787
Donor-Specific Antibodies Adversely Affect Kidney Allograft Outcomes
Mohan, S., Palanisamy, A., Tsapepas, D., Tanriover, B., Crew, R. J., Dube, G., Ratner, L. E., Cohen, D. J., & Radhakrishnan, J. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012070664 · Cited by 277
Desensitization Protocols and Their Outcome
Marfo, K., Lu, A., Ling, M., & Akalin, E. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08140910 · Cited by 272
Lee, S., Huh, J. Y., Turner, D. M., Lee, S., Robinson, J., Stein, J. E., Shim, S. H., Hong, C. P., Kang, M. S., Nakagawa, M., et al. (2018) · Stem Cells · doi:10.1002/stem.2865 · Cited by 99
Impact of Pretransplant Anti-HLA Antibodies on Outcomes in Lung Transplant Candidates
Kim, M., Townsend, K. R., Wood, I. G., Boukedes, S., Guleria, I., Gabardi, S., El-Chemaly, S., Camp, P. C., Chandraker, A. K., Milford, E. L., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2160oc · Cited by 72
Metadata
- Authors
- Amico, P., Hönger, G., Mayr, M., Steiger, J., Hopfer, H., & Schaub, S.
- Venue
- Transplantation
- Published
- 2009-06-15
- Volume
- 87
- Issue
- 11
- Pages
- 1681-1688
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2022076910
- Cited by
- 258
- References
- 19
- FWCI
- 14.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.